Continental Advisors LLC Myriad Genetics Inc Transaction History

Continental Advisors LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 15, 2021	SELL	$29.97 - $36.66 $134,865 - $164,969	-4,500 Reduced 15.31%	24,892 $804,000
Q1 2021 May 17, 2021	SELL	$19.92 - $31.6 $139,440 - $221,200	-7,000 Reduced 19.23%	29,392 $895,000
Q3 2020 Nov 16, 2020	BUY	$11.25 - $14.75 $253,125 - $331,875	22,500 Added 161.96%	36,392 $475,000
Q1 2019 May 14, 2019	SELL	$26.93 - $34.7 $326,068 - $420,147	-12,108 Reduced 46.57%	13,892 $461,000
Q4 2017 Feb 13, 2018	SELL	$28.45 - $37.14 $261,740 - $341,688	-9,200 Reduced 26.14%	26,000 $893,000
Q3 2017 Nov 14, 2017	BUY	$24.01 - $36.2 $845,152 - $1.27 Million	35,200	35,200 $1.27 Million

253

90.9M

100K

34K

Ticker MYGN
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 80,634,800
Market Cap $1.25B
Description
Myriad Genetics, Inc., a genetic testing and precision medicine company, develops and commercializes genetic tests in the United States and internationally. The company offers molecular diagnostic tests for use in oncology, and women's and mental health applications. It provides MyRisk Hereditary Cancer Test, a DNA sequencing test for assessing ...

Get notified when there are updates to the investment portfolio of Continental Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Continental Advisors LLC with notifications on news.